May 2006
Volume 47, Issue 13
ARVO Annual Meeting Abstract  |   May 2006
Subtype Selective Muscarinic Receptor Agonist With Ocular Hypotensive Properties
Author Affiliations & Notes
  • M.J. Ogidigben
    Ophthalmic, Merck, West, PA
  • T. Yamakawa
    Banyu Tsukuba Research Institute, Merck, Banyu, Japan
  • S. Yufu
    Banyu Tsukuba Research Institute, Merck, Banyu, Japan
  • L.A. O'Neill–Davis
    Ophthalmic, Merck, West, PA
  • L.A. Hettrick
    Ophthalmic, Merck, West, PA
  • Footnotes
    Commercial Relationships  M.J. Ogidigben, Merck & Co, F; T. Yamakawa, Merck & Co, F; S. Yufu, Merck & Co, F; L.A. O'Neill–Davis, Merck & Co, F; L.A. Hettrick, Merck & Co, F.
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science May 2006, Vol.47, 2949. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      M.J. Ogidigben, T. Yamakawa, S. Yufu, L.A. O'Neill–Davis, L.A. Hettrick; Subtype Selective Muscarinic Receptor Agonist With Ocular Hypotensive Properties . Invest. Ophthalmol. Vis. Sci. 2006;47(13):2949.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : The objectives of this study were: 1) to determine, in vitro, the muscarinic receptor subtype selectivity of 1–[1'–(2–Tolyl)–1,4'–bipiperidin–4–yl]–1,3–dihydro–2H–benzimidazol–2–one (TBPB): and 2) to examine, in vivo, its effect on ocular hypotension and miosis.

Methods: : Chinese hamster ovary (CHO) cells transfected with plasmid expressing human m1, m3, m4, and m5 were used to determine receptor selectivity of TBPB in a fluorometric imaging plate reader (FLPR) assay. Normotensive Dutch Belted rabbits were used to examine the effects of TBPB on intraocular pressure (IOP) and pupillary size upon topical application. In other studies, rabbits were dosed topically with TBPB in the absence and presence of pirenzepine, AF–DX 116 and 4–DAMP, M1, M2, and M3 receptor selective antagonists, respectively, to confirm the predominant muscarinic receptor subtype responsible for the ocular action of TBPB.

Results: : TBPB selectively activated m1 receptors with E–max of 91% compared to carbachol (100%) but no significant activation at other receptor subtypes were seen in this study. In contrast, pilocarpine did not show the selectivity exhibited by TBPB. Single, unilateral topical application of TBPB (25, 75, and 250 µg) elicited dose–dependent IOP reduction of 4.8, 6.3, and 7.0 mmHg, respectively, without change in pupillary size in Dutch Belted rabbits. The ocular hypotensive effect of TBPB (75 µg) was significantly antagonized (from 6.3 to 1.6 mmHg) by bilateral pretreatment with pirenzepine (750 µg), but not AF–DX 116 or 4–DAMP, suggesting predominant involvement of M1 receptors.

Conclusions: : The in vitro and in vivo data demonstrated that TBPB is a selective M1 agonist that lowers IOP in rabbits without eliciting miosis.

Keywords: anterior segment • aqueous • anterior chamber 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.